Home›Stock Screener›Aurobindo Pharma›P/E Ratio

Aurobindo Pharma P/E Ratio

Current P/E Ratio
23.56
Moderate Valuation
High - Growth expectations or overvalued

Aurobindo Pharma (AUROPHARMA) P/E ratio is 23.56 (Moderate), EPS (TTM) ₹59.81, current price ₹1389.50 on NSE vs historical average P/E of 16.78 (100.0th percentile) — High - Growth expectations or overvalued. For live price, revenue and the complete fundamental profile, see AUROPHARMA stock price BSE.

Current Valuation Metrics

P/E Ratio 23.56
Current Price ₹1389.50
EPS (TTM) ₹59.81
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 16.78
Historical Range 4.98 - 22.54
Percentile 100.0%

Sector Context

Sector Average 53.82
Sector Median 27.53
Sector Rank #11 of 192
Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹60.04
Sept 2025 ₹14.61
Mar 2025 ₹15.56

AUROPHARMA P/E Ratio — Valuation Signal & Historical Context

Aurobindo Pharma P/E 23.56 vs historical average 16.78, range 4.98–22.54 — signal: Overvalued. Browse AUROPHARMA complete financial statements for revenue, profit, balance sheet and cash flow data.

  • Current PE is 40.4% above historical average
  • Trading at discount to sector average PE of 53.82

Aurobindo Pharma P/E Ratio Historical Trend

AUROPHARMA annual price-to-earnings ratio — 10 years, EPS and year-end price. Current P/E 23.56 vs historical average 16.78. Analyse Aurobindo Pharma shareholding analysis to track promoter, FII and institutional holdings.

AUROPHARMA Historical P/E Ratio — EPS, Year-End Price & Valuation

Aurobindo Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 22.54 60.04 ₹1353.25 NSE Moderate
2024 18.07 59.76 ₹1080.15 NSE Moderate
2023 9.2 47.25 ₹434.80 NSE Low
2022 21.48 34.09 ₹732.10 NSE Moderate
2021 18.93 49.02 ₹927.75 NSE Moderate
2020 4.98 91.91 ₹458.10 NSE Low
2019 16.74 43.8 ₹733.15 NSE Moderate
2018 17.36 39.39 ₹683.95 NSE Moderate
2017 16.3 41.44 ₹675.50 NSE Moderate
2016 22.16 39.77 ₹881.40 NSE Moderate

AUROPHARMA vs Healthcare Peers — P/E Ratio Comparison

Aurobindo Pharma P/E 23.56 vs Healthcare average 53.82, median 27.53 — range 1.03–1007.14.

Sector Average
53.82
Sector Median
27.53
Lowest P/E
1.03
Highest P/E
1007.14
Companies
192
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.03 ₹36 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 4.19 ₹71 Low
Ind Swift Laboratories INDSWFTLAB 4.7 ₹1,105 Low
Amwill Health Care AMWILL 6.71 ₹71 Low
Shelter Pharma SHELTER 6.75 ₹49 Low
Mono Pharmacare MONOPHARMA 7.44 ₹23 Low
Zenith Drugs ZENITHDRUG 7.69 ₹68 Low
Par Drugs & Chemical PAR 8.09 ₹113 Low
Galaxy Medicare GML 8.65 ₹29 Low